229 related articles for article (PubMed ID: 28065501)
1. Synthesis, docking, cytotoxicity, and LTA
El-Naggar MH; Mira A; Abdel Bar FM; Shimizu K; Amer MM; Badria FA
Bioorg Med Chem; 2017 Feb; 25(3):1277-1285. PubMed ID: 28065501
[TBL] [Abstract][Full Text] [Related]
2. Novel [6]-gingerol Triazole Derivatives and their Antiproliferative Potential against Tumor Cells.
de Lima Silva WC; Conti R; de Almeida LC; Morais PAB; Borges KB; Júnior VL; Costa-Lotufo LV; de Souza Borges W
Curr Top Med Chem; 2020; 20(2):161-169. PubMed ID: 31880263
[TBL] [Abstract][Full Text] [Related]
3. Feasibility and physiological relevance of designing highly potent aminopeptidase-sparing leukotriene A4 hydrolase inhibitors.
Numao S; Hasler F; Laguerre C; Srinivas H; Wack N; Jäger P; Schmid A; Osmont A; Röthlisberger P; Houguenade J; Bergsdorf C; Dawson J; Carte N; Hofmann A; Markert C; Hardaker L; Billich A; Wolf RM; Penno CA; Bollbuck B; Miltz W; Röhn TA
Sci Rep; 2017 Oct; 7(1):13591. PubMed ID: 29051536
[TBL] [Abstract][Full Text] [Related]
4. Dual anti-inflammatory and selective inhibition mechanism of leukotriene A4 hydrolase/aminopeptidase: insights from comparative molecular dynamics and binding free energy analyses.
Appiah-Kubi P; Soliman ME
J Biomol Struct Dyn; 2016 Nov; 34(11):2418-33. PubMed ID: 26555301
[TBL] [Abstract][Full Text] [Related]
5. [6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase.
Jeong CH; Bode AM; Pugliese A; Cho YY; Kim HG; Shim JH; Jeon YJ; Li H; Jiang H; Dong Z
Cancer Res; 2009 Jul; 69(13):5584-91. PubMed ID: 19531649
[TBL] [Abstract][Full Text] [Related]
6. Identification of Human Leukotriene A4 Hydrolase Inhibitors Using Structure-Based Pharmacophore Modeling and Molecular Docking.
Audat SA; Al-Shar'i NA; Al-Oudat BA; Bryant-Friedrich A; Bedi MF; Zayed AL; Al-Balas QA
Molecules; 2020 Jun; 25(12):. PubMed ID: 32580506
[TBL] [Abstract][Full Text] [Related]
7. A sensitive fluorigenic substrate for selective in vitro and in vivo assay of leukotriene A4 hydrolase activity.
Poras H; Duquesnoy S; Fournié-Zaluski MC; Ratinaud-Giraud C; Roques BP; Ouimet T
Anal Biochem; 2013 Oct; 441(2):152-61. PubMed ID: 23851339
[TBL] [Abstract][Full Text] [Related]
8. Thermodynamic properties of leukotriene A
Wittmann SK; Kalinowsky L; Kramer JS; Bloecher R; Knapp S; Steinhilber D; Pogoryelov D; Proschak E; Heering J
Bioorg Med Chem; 2016 Nov; 24(21):5243-5248. PubMed ID: 27651294
[TBL] [Abstract][Full Text] [Related]
9. Hybrid Receptor-Bound/MM-GBSA-Per-residue Energy-Based Pharmacophore Modelling: Enhanced Approach for Identification of Selective LTA4H Inhibitors as Potential Anti-inflammatory Drugs.
Appiah-Kubi P; Soliman M
Cell Biochem Biophys; 2017 Mar; 75(1):35-48. PubMed ID: 27914004
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene A4 hydrolase as a target for cancer prevention and therapy.
Chen X; Wang S; Wu N; Yang CS
Curr Cancer Drug Targets; 2004 May; 4(3):267-83. PubMed ID: 15134534
[TBL] [Abstract][Full Text] [Related]
11. Comparative antioxidant and anti-inflammatory effects of [6]-gingerol, [8]-gingerol, [10]-gingerol and [6]-shogaol.
Dugasani S; Pichika MR; Nadarajah VD; Balijepalli MK; Tandra S; Korlakunta JN
J Ethnopharmacol; 2010 Feb; 127(2):515-20. PubMed ID: 19833188
[TBL] [Abstract][Full Text] [Related]
12. Anti-Cancer Effect of Gingerol in Cancer Prevention and Treatment.
Nafees S; Zafaryab M; Mehdi SH; Zia B; Rizvi MA; Khan MA
Anticancer Agents Med Chem; 2021; 21(4):428-432. PubMed ID: 32951584
[TBL] [Abstract][Full Text] [Related]
13. Gingerol-derivatives: emerging new therapy against human drug-resistant MCF-7.
Ibrahim AS; Sobh MA; Eid HM; Salem A; Elbelasi HH; El-Naggar MH; AbdelBar FM; Sheashaa H; Sobh MA; Badria FA
Tumour Biol; 2014 Oct; 35(10):9941-8. PubMed ID: 25004806
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the 5-Lipoxygenase Pathway by Chalcogen-Containing Inhibitors of Leukotriene A
Teder T; König S; Singh R; Samuelsson B; Werz O; Garscha U; Haeggström JZ
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108702
[TBL] [Abstract][Full Text] [Related]
15. The development of novel LTA
Low CM; Akthar S; Patel DF; Löser S; Wong CT; Jackson PL; Blalock JE; Hare SA; Lloyd CM; Snelgrove RJ
Sci Rep; 2017 Mar; 7():44449. PubMed ID: 28303931
[TBL] [Abstract][Full Text] [Related]
16. From a multipotent stilbene to soluble epoxide hydrolase inhibitors with antiproliferative properties.
Buscató E; Büttner D; Brüggerhoff A; Klingler FM; Weber J; Scholz B; Zivković A; Marschalek R; Stark H; Steinhilber D; Bode HB; Proschak E
ChemMedChem; 2013 Jun; 8(6):919-23. PubMed ID: 23596124
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene A4 hydrolase in rat and human esophageal adenocarcinomas and inhibitory effects of bestatin.
Chen X; Li N; Wang S; Wu N; Hong J; Jiao X; Krasna MJ; Beer DG; Yang CS
J Natl Cancer Inst; 2003 Jul; 95(14):1053-61. PubMed ID: 12865451
[TBL] [Abstract][Full Text] [Related]
18. Biological properties of 6-gingerol: a brief review.
Wang S; Zhang C; Yang G; Yang Y
Nat Prod Commun; 2014 Jul; 9(7):1027-30. PubMed ID: 25230520
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of [6]-gingerol analogues as transient receptor potential channel TRPV1 and TRPA1 modulators.
Morera E; De Petrocellis L; Morera L; Moriello AS; Nalli M; Di Marzo V; Ortar G
Bioorg Med Chem Lett; 2012 Feb; 22(4):1674-7. PubMed ID: 22257892
[TBL] [Abstract][Full Text] [Related]
20. Leukotriene A4 hydrolase: a critical role of glutamic acid-296 for the binding of bestatin.
Andberg M; Wetterholm A; Medina JF; Haeggström JZ
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):621-5. PubMed ID: 10642521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
